,outcome,arm 1,arm 2
0,intervention,TLC D-99 patients,doxorubicin patients
0,Protocol-defined cardiotoxicity,13 %,"29 %, 9 cases"
0,"Protocol-defined cardiotoxicity, total study group",CHF,CHF
